On the same rat model, scopoletin significantly alleviated clinical symptoms, immune responses, and joint pathological conditions (Chen et al., 2021); scopoletin was also proved to induce RA FLS apoptosis by inhibiting NF-κB activation (Li et al., 2009). This evidence concerns the gene NFKB1 and rheumatoid arthritis.